| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$230,344 |
|
|
|
Indirect Value
|
$201,533 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$431,877 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-12 |
4 |
AS |
$39.01 |
$152,139 |
I/I |
(3,900) |
342,138 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-26 |
4 |
AS |
$39.02 |
$152,221 |
I/I |
(3,900) |
93,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-11-22 |
4 |
AS |
$18.21 |
$152,964 |
I/I |
(8,400) |
388,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-09-18 |
4 |
AS |
$39.62 |
$154,518 |
I/I |
(3,900) |
62,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-27 |
4 |
AS |
$36.63 |
$155,421 |
I/I |
(4,200) |
206,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-29 |
4 |
AS |
$39.81 |
$155,637 |
I/I |
(3,900) |
319,937 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-10-05 |
4 |
AS |
$39.58 |
$155,777 |
I/I |
(3,900) |
50,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-09-07 |
4 |
AS |
$39.74 |
$155,881 |
I/I |
(3,900) |
66,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-09-19 |
4 |
AS |
$39.99 |
$155,961 |
I/I |
(3,900) |
58,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-04-22 |
4 |
AS |
$60.01 |
$156,026 |
I/I |
(2,600) |
394,900 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-07-17 |
4 |
AS |
$59.90 |
$156,388 |
I/I |
(2,600) |
385,382 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-03-14 |
4 |
AS |
$39.10 |
$156,906 |
I/I |
(3,900) |
331,637 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-10-04 |
4 |
AS |
$40.09 |
$157,976 |
I/I |
(3,900) |
54,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-07-16 |
4 |
AS |
$60.90 |
$159,292 |
I/I |
(2,600) |
387,982 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-06-04 |
4 |
AS |
$41.22 |
$159,911 |
I/I |
(3,800) |
403,582 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-04-23 |
4 |
AS |
$62.70 |
$163,020 |
I/I |
(2,600) |
392,300 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-11-29 |
4 |
AS |
$41.13 |
$163,232 |
I/I |
(3,900) |
27,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-08 |
4 |
AS |
$37.15 |
$163,460 |
I/I |
(4,400) |
287,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-09 |
4 |
AS |
$36.59 |
$165,969 |
I/I |
(4,400) |
282,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-12 |
4 |
AS |
$42.56 |
$165,984 |
I/I |
(3,900) |
23,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-13 |
4 |
AS |
$42.75 |
$166,725 |
I/I |
(3,900) |
19,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-10 |
4 |
AS |
$19.64 |
$171,938 |
I/I |
(8,600) |
380,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-05-09 |
4 |
AS |
$38.35 |
$172,305 |
I/I |
(4,400) |
184,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-26 |
4 |
AS |
$39.72 |
$176,448 |
I/I |
(4,400) |
210,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-26 |
4 |
AS |
$40.01 |
$177,370 |
I/I |
(4,400) |
158,078 |
0 |
- |
|
209 Records found
|
|
Page 7 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
